Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer

[1]  W. Xu,et al.  Research Progress in microRNA-Based Therapy for Gastric Cancer , 2019, OncoTargets and therapy.

[2]  D. Shanehbandi,et al.  Transcript Level of MicroRNA Processing Elements in Gastric Cancer , 2018, Journal of Gastrointestinal Cancer.

[3]  S. Mönig,et al.  Multimodal treatment in locally advanced gastric cancer , 2018, Updates in Surgery.

[4]  Ying Sun,et al.  Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer , 2018, Expert opinion on drug discovery.

[5]  Xiang Li,et al.  The role of talin2 in breast cancer tumorigenesis and metastasis , 2017, Oncotarget.

[6]  B. Baradaran,et al.  Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer. , 2017, Current medicinal chemistry.

[7]  Hai Li,et al.  The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis , 2017, Oncology letters.

[8]  L. Postovit,et al.  A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression , 2017, International journal of molecular sciences.

[9]  J. Trojan,et al.  LBA-008Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Gr , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Trojan,et al.  Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at , 2017 .

[11]  P. Wang,et al.  [Effect of microRNA-106b on the invasion and proliferation of trophoblasts through targeting MMP-2]. , 2017, Zhonghua fu chan ke za zhi.

[12]  Z. Benbrahim,et al.  Gastric Cancer: An Epidemiological Overview , 2017 .

[13]  C. Zhan,et al.  The molecular basis of talin2’s high affinity toward β1-integrin , 2017, Scientific Reports.

[14]  Kevin Kuhlmann,et al.  Impact of Polyunsaturated Fatty Acids on miRNA Profiles of Monocytes/Macrophages and Endothelial Cells—A Pilot Study , 2017, International journal of molecular sciences.

[15]  P. Calder.  Docosahexaenoic Acid , 2016, Annals of Nutrition and Metabolism.

[16]  K. Best,et al.  Docosahexaenoic Acid and Preterm Birth , 2016, Annals of Nutrition and Metabolism.

[17]  Hyeyoung Kim,et al.  Docosahexaenoic Acid Induces Oxidative DNA Damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells , 2016, International journal of molecular sciences.

[18]  G. Kweon,et al.  Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases , 2016, Oncotarget.

[19]  Ye Xu,et al.  Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell , 2016, BMC Cancer.

[20]  F. Velotti,et al.  Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy , 2016, Journal of clinical medicine.

[21]  Yuan Cheng,et al.  MicroRNA-106b is involved in transforming growth factor β1–induced cell migration by targeting disabled homolog 2 in cervical carcinoma , 2016, Journal of experimental & clinical cancer research : CR.

[22]  Xizhong Zhang,et al.  MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. , 2015, International journal of clinical and experimental pathology.

[23]  Y. Li,et al.  MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1 , 2015, Journal of experimental & clinical cancer research : CR.

[24]  X. Chen,et al.  Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway , 2015, PloS one.

[25]  Jin Gao,et al.  Prognostic value of miR-106b expression in breast cancer patients. , 2015, The Journal of surgical research.

[26]  Ying Sun,et al.  High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma , 2015, BMC Cancer.

[27]  Guoqiang Zhao,et al.  miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells , 2015, Tumor Biology.

[28]  Bo Zhou,et al.  MicroRNA‐106b in cancer‐associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN , 2014, FEBS letters.

[29]  X. Ying,et al.  MicroRNA-194 Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1 , 2014, Digestive Diseases and Sciences.

[30]  J. Sha,et al.  Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2 , 2013, Cancer science.

[31]  Congjian Xu,et al.  miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. , 2013, International journal of molecular medicine.

[32]  J. Lee,et al.  Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer , 2013, The Korean journal of internal medicine.

[33]  R. Poon,et al.  Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process , 2013, PloS one.

[34]  C. Pritchard,et al.  Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile , 2012, Biochemical and biophysical research communications.

[35]  R. Bast,et al.  Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer , 2012, PloS one.

[36]  H. Ford,et al.  The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer , 2012, Oncogene.

[37]  V. Yadav,et al.  The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis , 2011, Autoimmune diseases.

[38]  I. Brown,et al.  Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF‐κB pathway , 2008, The Prostate.

[39]  C. Croce,et al.  Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.

[40]  G. Pluhar,et al.  Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. , 2008, The Journal of nutritional biochemistry.

[41]  I. Judson,et al.  Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours , 2004, British Journal of Cancer.

[42]  Hong Zhao,et al.  Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. , 2003, World journal of gastroenterology.

[43]  T. Shuin,et al.  Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  B. Baradaran,et al.  Let-7a could serve as a biomarker for chemoresistance against docetaxel in gastric cancer. , 2018, Anti-cancer agents in medicinal chemistry.

[45]  Cong Chen,et al.  MiR-194 suppresses human gastric cancer cell proliferation and induces apoptosis by targeting GGCT , 2017 .